Abstract
Epoxyeicosatrienoic acids (EETs) are important endogenous substances that affect heart function in human body. Animal models of cytochrome P450 (CYP) and soluble epoxide hydrolase (sEH) related cardiovascular diseases (CVD) have revealed the physiological effects of EETs, mainly including vascular function regulation, angiogenesis, myocardial fibrosis, myocardial hypertrophy, and cardiovascular inflammation. At the same time, clinical studies have found that most of the substrates and inhibitors of CYP2J2 affect the content of EETs, resulting in cardiotoxicity of drugs. Therefore, the regulation of CYP and sEH enzymes on EETs points out the direction for exploring EET-mediated cardiac protection. The metabolic pathway of EETs is not only an important target for the development of new drugs for CVD but also an important factor in preventing drug cardiotoxicity. The development and clinical application of sEH inhibitors and EETs analogues provide broad prospects for the treatment of CVD.
| Original language | English |
|---|---|
| Article number | 121122 |
| Journal | Life Sciences |
| Volume | 310 |
| DOIs | |
| State | Published - 1 Dec 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiotoxicity
- Cardiovascular diseases (CVD)
- Cytochrome P450 2J (CYP2J)
- Epoxyeicosatrienoic acids (EETs)
- Soluble epoxide hydrolase (sEH)
Fingerprint
Dive into the research topics of 'Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver